Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knudsen

Showing results (321-330 of 466) with videos related to

Pageof 47
Sort By:
The Journal of Rheumatology|July 4, 2008
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcomeLene S Knudsen, Mette Klarlund, Henrik Skjødt, et al.
Scandinavian Journal of Immunology|June 11, 2009
Genome-wide gene expression profiling of SCID mice with T-cell-mediated ColitisD Brudzewsky, A E Pedersen, M H Claesson, et al.
Annals of the Rheumatic Diseases|November 21, 2008
Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measureU Møller Døhn, A Boonen, M L Hetland, et al.
Scientific Reports|October 18, 2017
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcomeNathan Ing, Fangjin Huang, Andrew Conley, et al.
Oncogene|January 31, 2019
Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancerErik S Knudsen, Vishnu Kumarasamy, Amanda Ruiz, et al.
Molecular and Cellular Biology|June 1, 2004
RB reversibly inhibits DNA replication via two temporally distinct mechanismsSteven P Angus, Christopher N Mayhew, David A Solomon, et al.
Molecular Therapy. Methods & Clinical Development|May 17, 2018
A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer ModelJunhui Hu, Shiruyeh Schokrpur, Maani Archang, et al.
The Journal of Biological Chemistry|November 24, 2001
Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signalingMatthew W Strobeck, David N Reisman, Ranjaka W Gunawardena, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2022
Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRTNathanael Kane, Tahmineh Romero, Silvia Diaz-Perez, et al.
Journal of Cellular Physiology|August 2, 2003
Tumor suppressor pRB functions as a co-repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcriptionSunita Gupta, Mai X Luong, Sylvia A Bleuming, et al.
Pageof 47

Showing results (321-330 of 466) with videos related to

Sort By:
Pageof 47
The Journal of Rheumatology|July 4, 2008
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcomeLene S Knudsen, Mette Klarlund, Henrik Skjødt, et al.
Scandinavian Journal of Immunology|June 11, 2009
Genome-wide gene expression profiling of SCID mice with T-cell-mediated ColitisD Brudzewsky, A E Pedersen, M H Claesson, et al.
Annals of the Rheumatic Diseases|November 21, 2008
Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measureU Møller Døhn, A Boonen, M L Hetland, et al.
Scientific Reports|October 18, 2017
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcomeNathan Ing, Fangjin Huang, Andrew Conley, et al.
Oncogene|January 31, 2019
Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancerErik S Knudsen, Vishnu Kumarasamy, Amanda Ruiz, et al.
Molecular and Cellular Biology|June 1, 2004
RB reversibly inhibits DNA replication via two temporally distinct mechanismsSteven P Angus, Christopher N Mayhew, David A Solomon, et al.
Molecular Therapy. Methods & Clinical Development|May 17, 2018
A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer ModelJunhui Hu, Shiruyeh Schokrpur, Maani Archang, et al.
The Journal of Biological Chemistry|November 24, 2001
Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signalingMatthew W Strobeck, David N Reisman, Ranjaka W Gunawardena, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2022
Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRTNathanael Kane, Tahmineh Romero, Silvia Diaz-Perez, et al.
Journal of Cellular Physiology|August 2, 2003
Tumor suppressor pRB functions as a co-repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcriptionSunita Gupta, Mai X Luong, Sylvia A Bleuming, et al.
Pageof 47